(Q36118673)

12 August 2017

1 reference

title

The incretins: a link between nutrients and well-being (English)

1 reference

12 August 2017

Rémy Burcelin

1

1 reference

12 August 2017

publication date

1 April 2005

1 reference

British Journal of Nutrition

12 August 2017

published in

1 reference

12 August 2017

volume

93 Suppl 1

1 reference

12 August 2017

page(s)

S147-56

1 reference

Comparison of the time courses of insulin and the portal signal on hepatic glucose and glycogen metabolism in the conscious dog.

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Glucose Inhibition of the Glucose-sensitive Neurone in the Rat Lateral Hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Low affinity binding of interleukin-1 beta and intracellular signaling via NF-kappa B identify Fit-1 as a distant member of the interleukin-1 receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37).

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Portal vein afferents are critical for the sympathoadrenal response to hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Intracerebroventricular injection of mammalian and chicken glucagon-like peptide-1 inhibits food intake of the neonatal chick.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Hypersecretion of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide in obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Differences in glucagon-like peptide-1 and GIP responses following sucrose ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Intraventricular GLP-1 reduces short- but not long-term food intake or body weight in lean and obese rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Glucose Counterregulation in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

The incretin concept today

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Portal glucose infusion in the mouse induces hypoglycemia: evidence that the hepatoportal glucose sensor stimulates glucose utilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Encapsulated, genetically engineered cells, secreting glucagon-like peptide-1 for the treatment of non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Evidence that extrapancreatic GLUT2-dependent glucose sensors control glucagon secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Electronimmunocytochemical evidence for the K cell localization of gastric inhibitory polypeptide (GIP) im man

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Regulation of Intestinal Proglucagon- Derived Peptide Secretion by Intestinal Regulatory Peptides*

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Glucagon-like peptide-1 (7-36) amide as a novel neuropeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Exon duplication and divergence in the human preproglucagon gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

The mechanism of pancreatic secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Convergence of hepatoportal glucose-sensitive afferent signals to glucose-sensitive units within the nucleus of the solitary tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

The inhibitory effect of glucagon-like peptide-1 (GLP-1) 7-36 amide on gastric acid secretion in humans depends on an intact vagal innervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Glucagon-like peptide-1 is a physiological incretin in rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Molecular cloning, functional expression, and signal transduction of the GIP‐receptor cloned from a human insulinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Signal transduction of the GLP-1-receptor cloned from a human insulinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Glucagon-like peptide-1 (7-36) amide: a central regulator of satiety and interoceptive stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Autoradiographic localization of receptors for glucagon-like peptide-1 (7-36) amide in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

A role for glucagon-like peptide-1 in the central regulation of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Glucose and osmosensitive neurones of the rat hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Blood glucose levels modulate efferent activity in the vagal supply to the rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Glucagon-like peptide 1 (GLP-1): a potent gut hormone with a possible therapeutic perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Sequence of an intestinal cDNA encoding human gastric inhibitory polypeptide precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Identification and localization of glucagon-like peptide-1 and its receptor in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Gastric emptying and release of incretin hormones after glucose ingestion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Insulinotropic action of glucagonlike peptide-I-(7-37) in diabetic and nondiabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

On the treatment of Diabetus mellitus by acid extract of Duodenal Mucous Membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

The isolation and sequencing of human gastric inhibitory peptide (GIP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

21 January 2018

Learning from the gut.

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Differential Processing of Proglucagon by the Subtilisin-like Prohormone Convertases PC2 and PC3 to Generate either Glucagon or Glucagon-like Peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Proglucagon is processed to glucagon by prohormone convertase PC2 in alpha TC1-6 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Insulinotropic actions of intravenous glucagon-like peptide-1 (GLP-1) [7-36 amide] in the fasting state in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Glucagon-like peptide-1 7-36: a physiological incretin in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Effects of glucagon-like peptide-1 (GLP-1) in RINm5F insulinoma cells. Stimulation of insulin secretion, insulin content, and insulin receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Non-linkage of the glucagon-like peptide 1 receptor gene with maturity onset diabetes of the young

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Secretion of the Incretin Hormones Glucagon-Like Peptide-1 and Gastric Inhibitory Polypeptide Correlates with Insulin Secretion in Normal Man Throughout the Day

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Extraction, gel filtration pattern, and receptor binding of porcine gastrointestinal glucagon-like immunoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

Short-term treatment with GLP-1 increases pulsatile insulin secretion in Type II diabetes with no effect on orderliness

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041340

21 January 2018

Identifiers

DOI

10.1079/BJN20041340

1 reference

12 August 2017

1 reference